SCHEMBL5311696

SCHEMBL5311696

COC(=O)c1cc(O)ccc1N(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 7/20 0.62
CA2 P00918 7/20 0.62
CA12 O43570 6/20 0.62
CA7 P43166 6/20 0.62
CA9 Q16790 6/20 0.62
CA14 Q9ULX7 6/20 0.62
PDK2 Q15119 1/20 0.58
PDK4 Q16654 1/20 0.58
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
AR P10275 1/20 0.43
EGFR P00533 2/20 0.42
GAA P10253 2/20 0.42
KMT2A Q03164 1/20 0.41
PTGS2 P35354 1/20 0.41
ESR2 Q92731 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL122553 0.82 KDM4E (0.54) CA1CA2CA12CA7CA9
SCHEMBL6161036 0.81 GAA (0.57) CA1CA2CA12CA7CA9
SCHEMBL4302570 0.81 NR4A2 (0.49) CA1CA2CA12CA7CA9
SCHEMBL4362314 0.81 ABL1 (0.56) LMNAGAAKMT2ASMN1; SMN2ALDH1A1
SCHEMBL31052715 0.81 KMT2A (0.44) CA1CA2CA12CA7CA9
SCHEMBL472317 0.79 ALDH1A1 (0.57) CA1CA2CA12CA7CA9
SCHEMBL158999 0.79 CA12 (0.74) CA1CA2CA12CA7CA9
SCHEMBL28986942 0.79 CA12 (0.50) CA1CA2CA12CA7CA9
SCHEMBL22445648 0.79 EGFR (0.42) CA1CA2CA12CA7CA9
SCHEMBL4211530 0.78 ALDH1A1 (0.50) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007058504-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2007-05-24 WO disclosed